US Stock MarketDetailed Quotes

MDWD MediWound

Watchlist

16.850
+0.500+3.06%

Trading Aug 6 12:27 ET

156.43MMarket Cap-12389P/E (TTM)

MediWound Stock Forum

Trytosaveabit

Jul 15 06:04

Update

$MediWound(MDWD.US)$ Mediwound Ltd - to Sell 1,453,488 Ordinary Shares at 17.20 PS

careful Llama_7306

Jul 5 08:47

$MediWound(MDWD.US)$ any thoughts??

Trytosaveabit

Jul 5 07:27

Hmm?

$MediWound(MDWD.US)$ Watching / Looking for confirmation of rumor that $Solventum(SOLV.US)$ is offering a $34 PS takeover bid?

Trytosaveabit

Jan 9 06:05

Update

$MediWound(MDWD.US)$ MediWound Says FDA Accepted For Review The Supplement To The NexoBrid BLA To Include Pediatric Patients With Severe Thermal Burns

Trytosaveabit

Dec 28, 2023 06:06

It’s a additional 6.7 Million in non dilutive funding

$MediWound(MDWD.US)$

Trytosaveabit

Dec 28, 2023 06:02

Update

$MediWound(MDWD.US)$ MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army 1 MINUTE AGO, 7:00 AM EST VIA GLOBENEWSWIRE

Trytosaveabit

Dec 21, 2023 07:16

Go ahead look at the daily chart since I brought this to your attention! Hehehe

$MediWound(MDWD.US)$ Dare ya!

Moomoo AI

Dec 19, 2023 01:55

MediWound's high P/S ratio and weaker growth forecast compared to the wider industry could worry investors. Without significant business improvement, the stock price may face a drop risk.

Optimistic Investors Push MediWound Ltd. (NASDAQ:MDWD) Shares Up 26% But Growth Is Lacking

Trytosaveabit

Nov 21, 2023 06:11

See no dilution coming?

$MediWound(MDWD.US)$ Existing Cash and Cash Equivalents Are Expected to Provide Sufficient Funds for the Company's Current Operating Plan Through Profitability

Trytosaveabit

Nov 21, 2023 06:10

Earnings win

$MediWound(MDWD.US)$ reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.44) by 45.45 percent. This is a 72.73 percent increase over losses of $(0.88) per share from the same period last year. The company reported quarterly sales of $4.78 million which beat the analyst consensus estimate of $4.74 million by 0.76 percent. This is a 17.70 percent decrease over sales of $5.80 million the same period last year.

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall